Press release
Rising Viral Infections Fueling Advancements In The Hepatitis C Market: Transformative Forces Shaping the Hepatitis C Market Landscape in 2025
Hepatitis C
What Will the Hepatitis C Industry Market Size Be by 2025?
The market encompassing hepatitis C has experienced swift expansion lately, projected to increase from a valuation of $67.17 billion in 2024 to $75.72 billion by 2025, reflecting a compound annual growth rate of 12.7%; this upswing during the past period has been fueled by factors such as established blood transfusion protocols, the prevalence of injection drug use, the former scarcity of therapeutic choices, and the introduction of direct-acting antiviral agents.
What's the Long-Term Growth Forecast for the Hepatitis C Market Size Through 2029?
The financial scope of the hepatitis C market is projected for substantial expansion over coming years, reaching a valuation of $132.21 billion by 2029, propelled by a compound annual growth rate (CAGR) of 15.0%. This anticipated surge in growth throughout the forecasting window is directly linked to worldwide initiatives aiming for eradication, enhancements in diagnostic capabilities and population screening, escalating expenditures in healthcare, the incorporation of remote medical services, and the advent of novel combination therapies. Key shifts expected to shape the market during this timeframe encompass greater availability and lower costs for therapeutic interventions, concentrated attention on populations at elevated risk, enhancements in how medications are formulated, increased inter-organizational cooperation and alliances, and the wider adoption of virtual care and digital platforms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report
What Are the Key Growth Drivers Fueling the Hepatitis C Market Expansion?
The escalating incidence of viral illnesses is anticipated to be the primary catalyst for the expansion of the hepatitis C market moving ahead. Viral infections, which are those triggered by a virus invading the body, are directly addressed by hepatitis C therapies, as these treatments work to eliminate the viral presence and subsequently rebuild the patient's immune defense mechanisms following the removal of the virus. To illustrate this trend, data released in August 2024 by the Centers for Disease Control and Prevention, a key health organization in the United States, showed a broad increase in the prevalence of Parvovirus B19, a type of seasonal respiratory viral illness, across every demographic bracket, climbing from a 3% rate observed between 2022 and 2024 to reach 10% by June 2024; notably, the sharpest escalation in prevalence was evident among youngsters between five and nine years old, where their rate surged dramatically from 15% during the 2022-2024 period to an impressive 40% as of June 2024. Moreover, the quantity of composite samples testing positive for Parvovirus B19 DNA experienced a substantial climb, moving from just 1.5% in December 2023 up to 19.9% in June 2024, clearly indicating that the surge in viral infections is furnishing substantial impetus to the growth trajectory of the hepatitis C market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp
What Are the Key Trends Driving Hepatitis C Market Growth?
Advancements in diagnostic technologies for hepatitis C are emerging as a major trend in the hepatitis C market. Leading companies in this market are embracing innovative technologies to maintain their competitive edge. For example, in July 2022, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical and diagnostics company, introduced the Elecsys HCV Duo immunoassay in countries recognizing the CE Mark. This immunoassay enables the simultaneous and independent detection of hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample. It assists in identifying patients who are recovering or showing signs of chronic infection, which could potentially progress to conditions such as liver cancer or other early-stage liver diseases.
How Is the Hepatitis C Market Segmented?
The hepatitis cmarket covered in this report is segmented -
1) By Type: Chronic Hepatitis C; Acute Hepatitis C; Other Types
2) By Treatment: Antiviral Drugs; Vaccine; Immune Modulator Drugs; Surgery; Other Treatments
3) By Diagnosis: Liver Biopsy; Blood Tests; Imaging Tests; Other Diagnosis
4) By Distribution Channel: Hospital And Retail Pharmacies; Online Pharmacies
5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Research Institutes; Home Care Settings
Subsegments:
1) By Chronic Hepatitis C: Genotype 1; Genotype 2; Genotype 3; Genotype 4; Genotype 5; Genotype 6
2) By Acute Hepatitis C: Symptomatic; Asymptomatic
3) By Other Types: Mixed Infections; Superinfection
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp
Which Companies Are Leading the Charge in Hepatitis C Market Innovation?
Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited
Which Regions Are Leading the Global Hepatitis C Market in Revenue?
North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Viral Infections Fueling Advancements In The Hepatitis C Market: Transformative Forces Shaping the Hepatitis C Market Landscape in 2025 here
News-ID: 4270771 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hepatitis
POC Diagnostics Encourages Timely Hepatitis Testing Amid WHO's Hepatitis D Carci …
Birmingham, 18th September, 2025:
The World Health Organization (WHO) recently classified Hepatitis D as a carcinogen and raised a global concern about its link to liver cancer. In response to this, POC Diagnostic, one of the renowned and leading providers of modern medical testing solutions, urges both individuals and healthcare providers to prioritise early Hepatitis recognition.
Timely detection of Hepatitis infections is critical to prevent severe health complications. POC Diagnostics is…
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…
